Stockscreener 앱 받기
7.69
5.41%
-0.44
시장 영업 전:
7.82
0.13
+1.69%
Aligos Therapeutics Inc 주식(ALGS)의 최신 뉴스
Smart tools for monitoring Aligos Therapeutics Inc.’s price actionFree Accurate Technical Trend Reversal Picks - Newser
Is it too late to sell Aligos Therapeutics Inc.Long-Term Allocation Strategy Summary Breakdown - Newser
Will Aligos Therapeutics Inc. price bounce be sustainableFree Conservative Long Term Growth Plans - Newser
Using Bollinger Bands to evaluate Aligos Therapeutics Inc.Weekly High Conviction Trade Setup Analysis - Newser
Ranking Aligos Therapeutics Inc. among high performing stocks via toolsFast Movement Forecast for Trading Success - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attentionFree Fast Exit and Entry Strategy Guide - Newser
What indicators show strength in Aligos Therapeutics Inc.Intraday Price Forecast Using Volume Models - Newser
Does Aligos Therapeutics Inc. show high probability of reboundSupport and Resistance Zone Summary Chart - Newser
News impact scoring models applied to Aligos Therapeutics Inc.Proven Trading System with Consistent Gains - Newser
Custom watchlist performance reports with Aligos Therapeutics Inc.Free Entry Alert Based on Volume Spikes - Newser
Can Aligos Therapeutics Inc. rally from current levelsSummary of Reliable Long-Term Trade Models - Newser
What's behind ALGS' volatile quarterly earnings? - AInvest
Will Aligos Therapeutics Inc. stock go up soonExpert-Backed High Yield Stock Watchlist - Newser
Is Aligos Therapeutics Inc. showing signs of accumulationConsistent Gain Plan with AI Support - Newser
How Efficient Is Aligos Therapeutics Inc. at Controlling Operating CostsTrend Reversal Watch with Entry Signals - Newser
Volatility clustering patterns for Aligos Therapeutics Inc.Free Proven Entry Plan With Low Risk Trade - Newser
Aligos Therapeutics Reports Q2 EPS of $1.53, Misses Consensus - AInvest
Aligos 2025 Q2 Earnings Sharp Loss as Net Income Plummets 413% - AInvest
Aligos Therapeutics Reports Q2 2025 Progress and Results - TipRanks
Aligos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Aligos Therapeutics reports Q2 EPS ($1.53), consensus ($2.54) - TipRanks
Aligos Therapeutics Reports Second Quarter 2025 Financial Results and Progress on Clinical Studies - Quiver Quantitative
Aligos Reports Breakthrough HBV Drug Results: 100% Patient Response in Phase 1 as Pivotal Trial Launches - Stock Titan
Best data tools to analyze Aligos Therapeutics Inc. stockSecure Asset Flow and Trend Pattern Analysis - Newser
How Aligos Therapeutics Inc. stock performs during market volatilitySwing Trade Planning with Consistent Setup - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceShort Squeeze Opportunities with Indicators - Newser
Moving Average Trends for Aligos Therapeutics Inc. Stock: What They IndicateRisk-Managed Swing Setup and Signal Analysis - Newser
Is Aligos Therapeutics Inc. a good long term investmentUnlock real-time stock alerts for quick profits - Jammu Links News
Aligos Therapeutics (ALGS) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Analyzing drawdowns of Aligos Therapeutics Inc. with statistical toolsFree Long Hold Safe Return Strategy - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):